Laser therapy on the repair of a large-gap transected sciatic nerve in a reinforced nerve conduit

Researchers at Central Taiwan University of Science and Technology, Taiwan, led by Prof. Liu, Dr. Shen and Mrs. Yang have developed a biodegradable nerve conduit containing genipin-cross-linked gelatin was annexed using beta-tricalcium phosphate (TCP) ceramic particles (Genipin-Gelatin-TCP, GGT) to bridge the transection of a 15 mm sciatic nerve in rats. The effects of LLL therapy on peripheral nerve restoration and regeneration have systematically investigated throughout the study period.

Very few studies have employed tubulation in combination with diode laser therapy to repair . Furthermore, very few researchers have investigated the influence of LLL therapy on in a biodegradable nerve conduit.

The study, reported on Neural Regeneration Research (Vol. 9, No.12, 2014), confirmed that combining the GGT nerve conduit with an LLL therapy system may be beneficial for the regeneration of nerves across long gaps, as well as for accelerating the reinnervation rate of nerves and improving recruitment in muscles. These benefits may in turn lead to improve functional and morphologic recovery of peripheral nerves. Further studies on the use of LLL therapy as a noninvasive treatment modality for various nerve diseases and injuries could pave the way for mainstream acceptance and standardization of this innovative therapy.

More information: Neural Regen Res. 2014;9(12): 1180-1182.

Related Stories

Race to nerve regeneration: faster is better

date Oct 03, 2011

A team of researchers led by Clifford Woolf and Chi Ma, at Children's Hospital Boston and Harvard Medical School, Boston, has identified a way to accelerate the regeneration of injured peripheral nerves in mice such that ...

Recommended for you

Researchers learn to measure aging process in young adults

date 12 hours ago

Looking around at a 20th high school reunion, you might notice something puzzling about your classmates. Although they were all born within months of each other, these 38-year-olds appear to be aging at different ...

New paradigm for treating 'inflammaging' and cancer

date 16 hours ago

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.